Building robust global regulatory strategies and plans that face regulatory reality.
Extensive global regulatory experience from overseeing major new medicines development projects through regulatory development (including CMC, nonclinical and clinical areas) to marketing authorisations in EU, US (incl. Advisory Committee preparations), Japan, China, Canada, Australia and a number of additional countries.
This experience will benefit your projects through extensive experience in how to navigate the regulatory landscape and build robust regulatory plans leading to solid regulatory dossiers optimised for your specific key markets and medicine candidates.
Building robust global regulatory strategies and plans that face regulatory reality.
Extensive global regulatory experience from overseeing major new medicines development projects through regulatory development (including CMC, nonclinical and clinical areas) to marketing authorisations in EU, US (incl. Advisory Committee preparations), Japan, China, Canada, Australia and a number of additional countries.
This experience will benefit your projects through extensive experience in how to navigate the regulatory landscape and build robust regulatory plans leading to solid regulatory dossiers optimised for your specific key markets and medicine candidates.